Načítá se...
Interventions for preventing high altitude illness: Part 2. Less commonly‐used drugs
BACKGROUND: High altitude illness (HAI) is a term used to describe a group of mainly cerebral and pulmonary syndromes that can occur during travel to elevations above 2500 metres (˜ 8200 feet). Acute mountain sickness (AMS), high altitude cerebral oedema (HACE) and high altitude pulmonary oedema (HA...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494375/ https://ncbi.nlm.nih.gov/pubmed/29529715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012983 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|